How I manage frontline transplant-eligible multiple myeloma in Italy
The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2020-09-01
|
| Seria: | Hematology Reports |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.pagepress.org/journals/index.php/hr/article/view/8954 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|